These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 29384067)

  • 1. Interplay of Gut Microbiota, Probiotics in Obesity: A Review.
    Pothuraju R; Sharma RK
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):212-220. PubMed ID: 29384067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
    Barengolts E
    Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological role of host microbiota in the development of obesity.
    Kobyliak N; Virchenko O; Falalyeyeva T
    Nutr J; 2016 Apr; 15():43. PubMed ID: 27105827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora].
    Drapkina OM; Korneeva ON
    Ter Arkh; 2016; 88(9):135-142. PubMed ID: 28635818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifidobacteria attenuate the development of metabolic disorders, with inter- and intra-species differences.
    Zhu G; Ma F; Wang G; Wang Y; Zhao J; Zhang H; Chen W
    Food Funct; 2018 Jun; 9(6):3509-3522. PubMed ID: 29892745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats.
    Chunchai T; Thunapong W; Yasom S; Wanchai K; Eaimworawuthikul S; Metzler G; Lungkaphin A; Pongchaidecha A; Sirilun S; Chaiyasut C; Pratchayasakul W; Thiennimitr P; Chattipakorn N; Chattipakorn SC
    J Neuroinflammation; 2018 Jan; 15(1):11. PubMed ID: 29316965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and metabolic syndrome.
    Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
    World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics, prebiotics, energy balance, and obesity: mechanistic insights and therapeutic implications.
    Molinaro F; Paschetta E; Cassader M; Gambino R; Musso G
    Gastroenterol Clin North Am; 2012 Dec; 41(4):843-54. PubMed ID: 23101690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the gut microbiota in energy metabolism and metabolic disease.
    Cani PD; Delzenne NM
    Curr Pharm Des; 2009; 15(13):1546-58. PubMed ID: 19442172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding how pre- and probiotics affect the gut microbiome and metabolic health.
    Bock PM; Martins AF; Schaan BD
    Am J Physiol Endocrinol Metab; 2024 Jul; 327(1):E89-E102. PubMed ID: 38809510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of probiotics therapy to obesity: a therapy that has gained considerable momentum.
    Kang Y; Cai Y
    Hormones (Athens); 2018 Jun; 17(2):141-151. PubMed ID: 29858841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents.
    Ejtahed HS; Soroush AR; Angoorani P; Larijani B; Hasani-Ranjbar S
    Horm Metab Res; 2016 Jun; 48(6):349-58. PubMed ID: 27203411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Western diets, gut dysbiosis, and metabolic diseases: Are they linked?
    Martinez KB; Leone V; Chang EB
    Gut Microbes; 2017 Mar; 8(2):130-142. PubMed ID: 28059614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of intestinal microbiota in the pathogenesis of metabolic diseases.
    Węgielska I; Suliburska J
    Acta Sci Pol Technol Aliment; 2016; 15(2):201-211. PubMed ID: 28071010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial Impact on Host Metabolism: Opportunities for Novel Treatments of Nutritional Disorders?
    Plovier H; Cani PD
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28597812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet-microbiota interactions as moderators of human metabolism.
    Sonnenburg JL; Bäckhed F
    Nature; 2016 Jul; 535(7610):56-64. PubMed ID: 27383980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.